WuXi AppTec (OTCMKTS:WUXIF – Get Free Report) is expected to post its resultson Tuesday, April 28th. Analysts expect WuXi AppTec to post earnings of $0.1774 per share and revenue of $1.5934 billion for the quarter.
WuXi AppTec Price Performance
WuXi AppTec stock opened at $13.88 on Tuesday. The stock has a 50-day simple moving average of $13.88 and a 200-day simple moving average of $14.11. WuXi AppTec has a fifty-two week low of $13.54 and a fifty-two week high of $16.80.
About WuXi AppTec
WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. The company provides end-to-end solutions spanning discovery biology, medicinal chemistry, preclinical safety assessment, clinical trial support, and large-scale manufacturing of small molecules, biologics and advanced therapies. By integrating scientific expertise with state-of-the-art laboratory and production facilities, WuXi AppTec enables clients to accelerate the development of new treatments while managing time and cost pressures.
Key service offerings include custom synthesis and process research for active pharmaceutical ingredients (APIs), biologics development and manufacturing, cell line development, gene therapy support, as well as comprehensive analytical and testing services.
Featured Stories
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
